DXR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Daxor Corp (DXR) is not a strong buy for a beginner, long-term investor at this moment. The stock is currently in a bearish trend with oversold technical indicators, but lacks positive short-term trading signals or recent news catalysts. While analysts have a favorable long-term outlook with a high price target, the lack of significant insider or hedge fund activity, combined with the absence of recent financial performance data, suggests waiting for more clarity before investing.
The technical indicators show a bearish trend. The MACD is negative and expanding downward, RSI is oversold at 16.938, and the stock is trading below key moving averages (SMA_200 > SMA_20 > SMA_5). The stock is near its S2 support level of 9.861, indicating potential downside risk.
Analysts have initiated coverage with a Buy rating and a $23 price target, citing Daxor's high-growth potential in the MedTech diagnostic space and its overlooked fundamental strength.
The stock is in a bearish technical trend with no recent news or significant trading activity from insiders, hedge funds, or Congress. Additionally, the stock has a projected negative return of -4.69% over the next month.
No financial performance data is available for analysis.
Lake Street initiated coverage with a Buy rating and a $23 price target, highlighting the company's growth potential in the MedTech diagnostic market and its overlooked fundamentals.
